Evidence map›Paper›PMID 31108875›Full record

ArticleViruses2019

Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine.

Abbie G Anderson, Cullen B Gaffy, Joshua R Weseli, Kelly L Gorres

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Challenges in Prescribing Clozapine in the Era of COVID-19: A Review Focused on Immunological Implications.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2021
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Abbie G AndersonDepartment of Chemistry & Biochemistry, University of Wisconsin-La Crosse, 1725 State St., La Crosse, WI 54601, USA. anderson.abbie@uwlax.edu.
Cullen B GaffyDepartment of Chemistry & Biochemistry, University of Wisconsin-La Crosse, 1725 State St., La Crosse, WI 54601, USA. gaffy.cullen@uwlax.edu.
Joshua R WeseliDepartment of Chemistry & Biochemistry, University of Wisconsin-La Crosse, 1725 State St., La Crosse, WI 54601, USA. weseli.joshua@uwlax.edu.
Kelly L GorresDepartment of Chemistry & Biochemistry, University of Wisconsin-La Crosse, 1725 State St., La Crosse, WI 54601, USA. kgorres@uwlax.edu.
University of Wisconsin–La Crosse · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epstein-Barr virus (EBV), a member of the

Indexed as

Antipsychotic AgentsBurkitt LymphomaCell Line, TumorClozapineDose-Response Relationship, DrugEpstein-Barr Virus InfectionsGene Expression Regulation, ViralHerpesvirus 4, HumanHumansImmediate-Early ProteinsPhosphoproteinsTrans-ActivatorsVirus ActivationVirus LatencyAntipsychotic AgentsBRLF1 protein, Human herpesvirus 4BZLF1 protein, Herpesvirus 4, HumanClozapineclozapine N-oxideImmediate-Early ProteinsnorclozapinePhosphoproteinsSM protein, Human herpesvirus 4Trans-Activatorsantipsychotic drugantiviral drugBurkitt lymphoma cellsclozapineEpstein–Barr virusherpes viruseslytic gene expression

Identifiers

PMID31108875
PMCPMC6563273
OpenAlexW2946685563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.